Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-day crossover study of CPC mouthrinse for plaque inhibition
NL-OMON31893Not yet recruiting
- Sponsor
- Dentaid
- Start
- May 2008
- Modality
- Small Molecules, Conventional Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Trial of cetylpyridinium chloride and hexetidine in gingivitis (3 arms), sponsored by Dentaid. Primary endpoint: Quigley and Hein plaque index. Planned start May 2008; status: not yet recruiting.
02
Drugs
cetylpyridinium chloridehexetidine
03
Conditions
gingivitis
Beyond the preview
Go deeper on NL-OMON31893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31893.